Table 1 Characteristics of all SARI patients, and by status (alive/dead)
All patients n = 258 | Alive n = 228 | Dead n = 30 | p value | |
|---|---|---|---|---|
Demographic Characteristics | n (%) | n (%) | n (%) | |
Age (median, range) | 63 (19–97) | 62 (19–97) | 72 (35–88) | 0.006 |
Age ≥ 65 years | 135 (52%) | 113 (50%) | 22 (73%) | 0.018 |
Sex (female) | 121 (47%) | 108 (47%) | 13 (43%) | 0.677 |
Race/Ethnicity | 0.874 | |||
Asian | 4 (2%) | 3 (1%) | 1 (3%) | |
African American | 6 (2%) | 5 (3%) | 1 (3%) | |
Hispanic | 101 (39%) | 89 (40%) | 12 (40%) | |
Native American | 16 (6%) | 15 (7%) | 1 (3%) | |
White, non-Hispanic | 131 (51%) | 116 (49%) | 15 (50%) | |
Clinical Characteristics | ||||
Duration of hospital stay (median; range) | 5 (0–57) | 5 (0–57) | 6 (0–28) | 0.482 |
Days to seek care (median; range) | 4 (0–10) | 4 (0–10) | 3 (1–7) | 0.288 |
Admission to intensive care unit | 96 (37%) | 74 (32%) | 22 (73%) | <.0001 |
Clinical suspicion of pneumoniaa | 184 (71%) | 159 (70%) | 25 (83%) | 0.175 |
≥ 3 Comorbidities | 75 (29%) | 64 (28%) | 11 (36%) | 0.332 |
≥ 1 Comorbidity | 207 (80%) | 180 (78%) | 27 (90%) | 0.165 |
Cardiac disease | 69 (26%) | 61 (26%) | 8 (26%) | 0.992 |
Hypertension | 125 (48%) | 108 (47%) | 17 (56%) | 0.340 |
Lung disease | 84 (33%) | 72 (31%) | 12 (40%) | 0.357 |
Obesity | 29 (11%) | 26 (11%) | 3 (10%) | 0.810 |
Immunodeficiency | 23 (9%) | 18 (8%) | 5 (17%) | 0.122 |
Neurological disorder | 15 (6%) | 13 (6%) | 2 (6%) | 0.832 |
Laboratory Resultsb | n = 253 | n = 223 | n = 30 | |
Influenza virus (A or B) | 47 (19%) | 43 (19%) | 4 (13%) | 0.464 |
Parainfluenza virus (1, 2 or 3) | 13 (5%) | 12 (5%) | 1 (3%) | 0.653 |
Coronavirus (OC43, HKU1, NL63, 229E) | 14 (6%) | 12 (5%) | 2 (6%) | 0.750 |
Human metapneumovirus | 20 (8%) | 18 (8%) | 2 (6%) | 0.754 |
Respiratory syncytial virus | 8 (3%) | 8 (3%) | n/a | |
Rhinovirus | 10 (4%) | 9 (4%) | 1 (3%) | 0.870 |
Any viral pathogenc | 113 (45%) | 103 (46%) | 10 (33%) | 0.410 |